End

Lands’ End Announces Fourth Quarter and Full Year Fiscal 2023 Results

Retrieved on: 
Wednesday, March 27, 2024
Growth, End, International, Capital expenditure, Third party, Inventory, Share repurchase, Fiscal, Delta Air Lines, Video game

DODGEVILLE, Wis., March 27, 2024 (GLOBE NEWSWIRE) -- Lands’ End, Inc. (NASDAQ: LE) today announced financial results for the fourth quarter and full year of the fiscal year ended February 2, 2024. The Company also provided the first quarter and full year fiscal 2024 outlook.

Key Points: 
  • Excluding Lands’ End Japan in the fourth quarter of fiscal 2022, Global eCommerce net revenue decreased 0.6%.
  • Compared to fourth quarter of fiscal 2022, which included the results of Lands’ End Japan, International eCommerce Net revenue decreased 20.2%.
  • Outfitters Net revenue was $53.7 million for fourth quarter of fiscal 2023, a decrease of $6.8 million or 11.3% from $60.5 million during the fourth quarter of fiscal 2022.
  • Adjusted EBITDA was $31.7 million in the fourth quarter of fiscal 2023 compared to $24.2 million in the fourth quarter of fiscal 2022.

Virtual Internet Announces Virtual 5G Service Provider Control

Retrieved on: 
Monday, April 8, 2024
Cloud, Telephone, Speedtest.net, Primary, EV, Worldwide, End user, Mobile phone, Memory, Risk, Accounting, SAN, Frequency, Location, Internet, Data, Tablet, Health care, Radio access network, GPS, Communication, Life, IP address, Reliability, City, Service, Data-rate units, End, Investment, Service provider, RAN, Central processing unit, Secondary, Android

Virtual 5G --The Global 5G Cloud

Key Points: 
  • SINGAPORE and SAN JOSE, Calif., April 8, 2024 /PRNewswire/ -- Virtual Internet has announced Virtual 5G Service Provider Control, enabling V5G Users with the insight to manage the Service Provider and Device selections.
  • Virtual 5G uniquely delivers Global 5G service over any service provider network, even when the underlying Service Provider connection is not 5G, to End User devices that are also not 5G.
  • Virtual 5G Service Provider Control enables gathering Android hardware data and valuable insights into your device's operations, enabling Virtual 5G users to make selections that troubleshoot service provider issues and optimize performance.
  • Virtual 5G and Virtual 5G Service Provider Control can be the difference in successfully reaching charging resources in time.

Lands' End Announces $25 Million Share Repurchase Authorization

Retrieved on: 
Friday, March 15, 2024
Share repurchase, Hand, End, Security (finance)

The Company’s prior share repurchase authorization pursuant to which 2.3 million shares were repurchased for an aggregate $20.3 million beginning in June 2022, expired on February 2, 2024.

Key Points: 
  • The Company’s prior share repurchase authorization pursuant to which 2.3 million shares were repurchased for an aggregate $20.3 million beginning in June 2022, expired on February 2, 2024.
  • All repurchases will be subject to compliance with the Company’s Term Loan credit agreement which imposes a per fiscal year limitation on share repurchases.
  • Bernard McCracken, Chief Financial Officer, said, “This new share repurchase authorization demonstrates the Board and management team’s confidence in Lands’ End’s strategy and commitment to shareholder value creation.
  • The share repurchase program may be suspended or discontinued at any time.

Oportun Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, March 12, 2024
Growth, Rate, EPS, ROE, Acquisition, Sale, Principal balance, Adjustment, End, GAAP, Earnings, Marketing

Originations – Aggregate Originations for the fourth quarter were $437 million, a decrease of 28% as compared to $610 million in the prior-year quarter.

Key Points: 
  • Originations – Aggregate Originations for the fourth quarter were $437 million, a decrease of 28% as compared to $610 million in the prior-year quarter.
  • Portfolio Yield – Portfolio Yield as of the end of fourth quarter was 32.7%, an increase of 100 basis points as compared to 31.7% in the prior-year quarter.
  • Revenue – Total revenue for the fourth quarter was $263 million, essentially flat as compared to total revenue of $262 million in the prior-year quarter.
  • Cost of Debt was 7.1% for the fourth quarter of 2023 as compared to 4.8% for the prior-year quarter.

Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, February 27, 2024
Licensure, Investment, Growth, Exercise, Tolerability, Immunization, Host, Trial of the century, Ageing, PCV20, PCV, P-value, Safety, BLA, Success, Phase 10, Genetically modified bacteria, Net, G&A, CMC, SAN, Research and development, ID, OPA, Conference, The Lancet, Biologics license application, Breakthrough therapy, Advisory Committee, PCV15, POC, FDA, End, Food, Breakthrough, Element, Fireside chats, Administration, IPD

-- Significant Progress in Establishing Global Commercial Manufacturing Capacity for Vaxcyte's PCV Candidates, Including Expanded Collaboration with Lonza --

Key Points: 
  • ET / 1:30 p.m. PT --
    SAN CARLOS, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.
  • Additionally, as part of ongoing Chemistry, Manufacturing and Controls (CMC)-focused discussions, Vaxcyte received encouraging input from the FDA regarding the VAX-24 adult licensure requirements.
  • The six-month safety data from both studies showed safety and tolerability results for VAX-24 similar to PCV20 at all doses studied.
  • Vaxcyte will host a conference call and webcast to discuss this announcement today, February 27, 2024, at 4:30 p.m.

Vaxcyte Provides Clinical and Regulatory Progress Update on Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) Franchise

Retrieved on: 
Thursday, January 4, 2024
Licensure, Food, PCV, End, Breakthrough therapy, FDA, CMC, Ageing, Phase 10, SAN, Pivotal, Biologics license application, Advisory Committee, PCV20, Breakthrough, Data monitoring committee, Immunization, Initiation, IPD, PCV15, Infant, Safety, Tolerability, Genetically modified bacteria, BLA, Vaccine

-- Enrollment in Ongoing VAX-24 Infant Phase 2 Study Continues to Progress; Topline Data from Primary Immunization Series Expected by End of First Quarter of 2025, Followed by Topline Data from Booster Dose by End of 2025 --

Key Points: 
  • Vaxcyte’s carrier-sparing PCV franchise candidates, including VAX-24, a 24-valent PCV proceeding to Phase 3, and VAX-31, the Company’s next-generation 31-valent PCV, are being studied for the prevention of invasive pneumococcal disease (IPD).
  • The VAX-24 Phase 2 infant study continues to enroll participants in the second and final stage of the study.
  • This is a randomized, observer-blind, dose-finding two-stage clinical study evaluating the safety, tolerability and immunogenicity of VAX-24 in healthy infants.
  • Topline safety, tolerability and immunogenicity data from the ongoing adult Phase 1/2 study in the third quarter of 2024.

Brad Jacobs to Enter Building Products Distribution Industry

Retrieved on: 
Monday, December 11, 2023
Annual report, Comparison (grammar), Ecosystem, Failure, End, Risk, Sale, Acquisition, Robotics, B2B, United Rentals, HVAC, XPO, JPE, Water, Ageing, Weather, Growth, TENS, Investment, Automation, History, Communication, Security (finance)

GREENWICH, Conn., Dec. 11, 2023 (GLOBE NEWSWIRE) -- After a comprehensive year-long search, Brad Jacobs has announced his intention to create a market leader in building products distribution — an industry with approximately $800 billion in annual revenue between North America and Europe, according to industry estimates. The company will be called QXO, Inc.

Key Points: 
  • The company will be called QXO, Inc.
    “QXO’s strategy is to create a tech-forward leader in the building products distribution industry through accretive M&A and organic growth, including greenfield openings, with the goal of generating outsized stockholder value,” Jacobs said.
  • Distributors of building products offer materials, finished goods, value-added solutions and expertise to a broad range of customers across residential, nonresidential, industrial and infrastructure end-markets.
  • The building products distribution industry is highly fragmented, with approximately 7,000 distributors in North America and 13,000 in Europe, according to industry observers.
  • The industry has generated compound annual revenue growth of 7% over the last five years, based on industry data, and continues to benefit from powerful secular growth drivers for building products distribution in the residential, nonresidential and infrastructure sectors.

Lands’ End Announces Third Quarter Fiscal 2023 Results

Retrieved on: 
Tuesday, December 5, 2023
Marketing, Capital expenditure, Cyber Monday, Delta Air Lines, Collection, International, Inventory, Target, E-commerce, End, Black Friday, Share repurchase, Growth, Third party, Video game

DODGEVILLE, Wis., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Lands’ End, Inc. (NASDAQ: LE) today announced financial results for the third quarter ended October 27, 2023.

Key Points: 
  • DODGEVILLE, Wis., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Lands’ End, Inc. (NASDAQ: LE) today announced financial results for the third quarter ended October 27, 2023.
  • Compared to third quarter of fiscal 2022, which included the results of Lands’ End Japan, International eCommerce net revenue decreased 30.9%.
  • Outfitters Net revenue was $74.3 million for third quarter of fiscal 2023, a decrease of $6.5 million or 8.0% from $80.8 million during the third quarter of fiscal 2022.
  • Adjusted EBITDA was $17.3 million in the third quarter of fiscal 2023 compared to $16.7 million in the third quarter of fiscal 2022.

New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023

Retrieved on: 
Monday, November 13, 2023
Twilight anesthesia, Spondylosis, ASRA, Safety, TKA, Chronic pain, End, Bandage, Therapy, Adhesive, Spine, SPR, Patient, Cohort (statistics), PNS, Pain management, Joint, Pain, Diagnosis, Randomized controlled trial, Medicare, Society, Skin, Quality of life, Neuropathic pain, SPRINT, Dentistry, Treatment

CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- At the 22nd Annual American Society of Regional Anesthesia (ASRA) Pain Medicine Meeting in New Orleans, three posters on the SPRINT® PNS System were shared for the first time.

Key Points: 
  • CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- At the 22nd Annual American Society of Regional Anesthesia (ASRA) Pain Medicine Meeting in New Orleans, three posters on the SPRINT® PNS System were shared for the first time.
  • The first poster, “Percutaneous PNS Relieves Persistent Postoperative Pain and Improves Function after TKA: Results from a Placebo-Controlled Randomized Controlled Trial” was recognized with a President’s Choice Award from ASRA.
  • This poster highlights the results from a prospective trial evaluating the impact of SPRINT peripheral nerve stimulation (PNS) used for chronic knee pain after total knee arthroplasty (TKA) surgery.
  • The SPRINT PNS treatment group (n=18) demonstrated a 47 percent improvement in walking ability measured by a six-minute walk test whereas the placebo group (n=20) demonstrated a nine percent decrease.

Oportun Reports Third Quarter 2023 Financial Results

Retrieved on: 
Monday, November 6, 2023
Sale, Principal balance, Rate, Earnings per share, Earnings, EBITDA, Largest gold companies, GAAP, End, Acquisition, Growth, EPS, Annual percentage rate, Credit, Wealth, Bank, Video game, Pharmaceutical industry, Adjustment, ROE

SAN CARLOS, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Oportun Financial Corporation (Nasdaq: OPRT) (“Oportun”, or the "Company") today reported financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Originations – Aggregate Originations for the third quarter were $483 million, a decrease of 24% as compared to $634 million in the prior-year quarter.
  • Revenue – Total revenue for the third quarter was $268 million, an increase of 7% as compared to $250 million in the prior-year quarter.
  • Net revenue for the third quarter was $85 million, a decrease of 42% as compared to net revenue of $147 million in the prior-year quarter.
  • Oportun is providing the following guidance for 4Q 2023 and full year 2023 as follows: